CD8A and neoplasm: The findings demonstrated significant differences between patients in the high and low-risk groups in terms of activated dendritic cells (aDCs), CD8 + T cells, macrophages, mast cells, T helper cells, T follicular helper (Tfh), T helper type 1 (Th1), T helper type 2 (Th2), tumor-infiltrating lymphocytes (TIL), and regulatory T cells (Treg) (Figure 8C).